What the U.S. did wrong on Covid-19 — and what others did right
When it comes to public health communications and Covid-19, an expert sees clear differences between countries around the world.
When it comes to public health communications and Covid-19, an expert sees clear differences between countries around the world.
The U.S. Food and Drug Administration (FDA) has declined to approve Eli Lilly’s drug to treat a type of skin disease due to certain findings…
3 in 4 parents are concerned about the impact of air quality problems on their child’s health. 2 in 3 parents report poor or unhealthy…
But they acknowledge that taking the only shelf-accessible product off the market raises issues
Nestlé announced Monday the divestment of its peanut allergy treatment business Palforzia (peanut allergen powder-dnfp) to Stallergenes Greer for an undisclosed sum. Nestlé kicked off…
From body bags for rapid cooling to “prescriptions” for air conditioners, doctors are preparing for a future of extreme heat linked to climate change.
New research ties hearing aids to slower cognitive decline in those at higher risk of dementia.
Pharmaceutical giant Johnson & Johnson is the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.
“GPT-4, being trained off of our own textual communication, shows the same — or maybe even more exaggerated — racial and sex biases as humans”…
The new Pfizer partnership with Flagship will fund the development of up to 10 drug candidates.
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.